PMID- 36653889 OWN - NLM STAT- MEDLINE DCOM- 20230324 LR - 20240215 IS - 2233-6087 (Electronic) IS - 2233-6079 (Print) IS - 2233-6079 (Linking) VI - 47 IP - 2 DP - 2023 Mar TI - Genome-Wide Association Study on Longitudinal Change in Fasting Plasma Glucose in Korean Population. PG - 255-266 LID - 10.4093/dmj.2021.0375 [doi] AB - BACKGROUND: Genome-wide association studies (GWAS) on type 2 diabetes mellitus (T2DM) have identified more than 400 distinct genetic loci associated with diabetes and nearly 120 loci for fasting plasma glucose (FPG) and fasting insulin level to date. However, genetic risk factors for the longitudinal deterioration of FPG have not been thoroughly evaluated. We aimed to identify genetic variants associated with longitudinal change of FPG over time. METHODS: We used two prospective cohorts in Korean population, which included a total of 10,528 individuals without T2DM. GWAS of repeated measure of FPG using linear mixed model was performed to investigate the interaction of genetic variants and time, and meta-analysis was conducted. Genome-wide complex trait analysis was used for heritability calculation. In addition, expression quantitative trait loci (eQTL) analysis was performed using the Genotype-Tissue Expression project. RESULTS: A small portion (4%) of the genome-wide single nucleotide polymorphism (SNP) interaction with time explained the total phenotypic variance of longitudinal change in FPG. A total of four known genetic variants of FPG were associated with repeated measure of FPG levels. One SNP (rs11187850) showed a genome-wide significant association for genetic interaction with time. The variant is an eQTL for NOC3 like DNA replication regulator (NOC3L) gene in pancreas and adipose tissue. Furthermore, NOC3L is also differentially expressed in pancreatic beta-cells between subjects with or without T2DM. However, this variant was not associated with increased risk of T2DM nor elevated FPG level. CONCLUSION: We identified rs11187850, which is an eQTL of NOC3L, to be associated with longitudinal change of FPG in Korean population. FAU - Jin, Heejin AU - Jin H AD - Institute of Health and Environment, Seoul National University, Seoul, Korea. FAU - Kwak, Soo Heon AU - Kwak SH AD - Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. FAU - Yoon, Ji Won AU - Yoon JW AD - Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea. FAU - Lee, Sanghun AU - Lee S AD - Department of Bioconvergence & Engineering, Dankook University, Yongin, Korea. FAU - Park, Kyong Soo AU - Park KS AD - Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. AD - Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. AD - Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea. FAU - Won, Sungho AU - Won S AD - Institute of Health and Environment, Seoul National University, Seoul, Korea. AD - Department of Public Health Sciences, Seoul National University, Seoul, Korea. AD - RexSoft Inc., Seoul, Korea. FAU - Cho, Nam H AU - Cho NH AD - Department of Preventive Medicine, Ajou University School of Medicine, Suwon, Korea. LA - eng PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't DEP - 20230119 PL - Korea (South) TA - Diabetes Metab J JT - Diabetes & metabolism journal JID - 101556588 RN - 0 (Blood Glucose) RN - 0 (NOC3L protein, human) SB - IM MH - Humans MH - Blood Glucose/analysis MH - *Diabetes Mellitus, Type 2/epidemiology/genetics MH - Fasting MH - *Genome-Wide Association Study MH - Prospective Studies MH - Republic of Korea/epidemiology PMC - PMC10040618 OTO - NOTNLM OT - Genome-wide association study OT - Hyperglycemia OT - Longitudinal studies COIS- CONFLICTS OF INTEREST Sungho Won has no a relevant financial interest with RexSoft, Inc.. EDAT- 2023/01/19 06:00 MHDA- 2023/03/24 06:00 PMCR- 2023/03/01 CRDT- 2023/01/18 23:41 PHST- 2021/12/29 00:00 [received] PHST- 2022/04/27 00:00 [accepted] PHST- 2023/01/19 06:00 [pubmed] PHST- 2023/03/24 06:00 [medline] PHST- 2023/01/18 23:41 [entrez] PHST- 2023/03/01 00:00 [pmc-release] AID - dmj.2021.0375 [pii] AID - dmj-2021-0375 [pii] AID - 10.4093/dmj.2021.0375 [doi] PST - ppublish SO - Diabetes Metab J. 2023 Mar;47(2):255-266. doi: 10.4093/dmj.2021.0375. Epub 2023 Jan 19.